BANGKOK, 23rd October 2018 (NNT) – The Health Systems Research Institute (HSRI) joined a fundraising drive to help a team of researchers at Chulalongkorn University (CU) continue their 1.5-billion-baht project to develop a new anti-cancer drug.
The project aims to develop an anti-cancer drug in a bid to replace costly imported medicines.
The HSRI Director, Dr. Nopporn Cheanklin, said on Tuesday that the institute had granted 10 million baht to the research team at the Faculty of Medicine.
Dr. Nopporn said this will be progress for the healthcare system and provide new hope for patients.
The research applies “immunotherapy”, a technique using human immune system to combat cancer rather than relying on traditional treatments, such as surgery, radiation therapy, and chemotherapy, which can lead to severe side effects.
Since medicine derived from the immune system can be expensive, especially if it is imported, the local researchers hope to use the same technology to produce an affordable local variant.
Source : NNT